Gastroenterology Department, Liaocheng People's Hospital, Liaocheng, China.
Gastrointestinal Surgery Department, Liaocheng People's Hospital, Liaocheng, China.
J Clin Lab Anal. 2023 Jan;37(2):e24825. doi: 10.1002/jcla.24825. Epub 2023 Jan 2.
BACKGROUND: As EIF3D is oncogenic in colorectal cancer (CRC) and is associated with multidrug resistance, this study aims to investigate whether and how EIF3D regulates resistance to 5-fluorouracil (5-Fu) in CRC. METHODS: EIF3D-associated genes in CRC were predicted using bioinformatics tools. CRC cells and nude mice received 5-Fu treatment. Then, the impacts of EIF3D and the interaction between EIF3D and RUVBL1 on cell viability, colony formation, apoptosis, and DNA damage were detected through MTT, colony formation, flow cytometry, and immunofluorescence assays, and those on in vivo tumorigenesis through murine xenograft assay. IC50 value of 5-Fu for CRC cells was determined by probit regression analysis. Expressions of EIF3D, eIF4E, EIF3D-associated genes, γH2AX, Bcl-2, Bax, and Cleaved Caspase-3/Caspase-3 in CRC tissues, cells, and/or xenograft tumors were analyzed by qRT-PCR and/or Western blot. RESULTS: EIF3D and RUVBL1 were highly expressed and positively correlated with CRC tissues/cells. In CRC cells, except for eIF4E, both EIF3D and RUVBL1 levels were upregulated by 5-Fu treatment; in addition to that, RUVBL1 level was downregulated by EIF3D silencing rather than eIF4E. Meanwhile, EIF3D silencing diminished IC50 value of 5-Fu and potentiated 5-Fu-induced viability decrease, colony formation inhibition, apoptosis promotion, Bcl-2 downregulation, and γH2AX, Bax, and Cleaved Caspase-3/Caspase-3 upregulation but reversed 5-Fu-triggered RUVBL1 upregulation. RUVBL1 overexpression offsets EIF3D silencing-induced viability decrease and apoptosis promotion of 5-Fu-treated CRC cells, and tumorigenesis suppression and apoptosis promotion in 5-Fu-treated mice. CONCLUSION: EIF3D promotes resistance to 5-Fu in CRC through upregulating RUVBL1 level.
背景:EIF3D 在结直肠癌(CRC)中具有致癌性,并与多药耐药性相关,因此本研究旨在探讨 EIF3D 是否以及如何调节 CRC 对 5-氟尿嘧啶(5-Fu)的耐药性。
方法:使用生物信息学工具预测 CRC 中与 EIF3D 相关的基因。给予 CRC 细胞和裸鼠 5-Fu 处理。然后,通过 MTT、集落形成、流式细胞术和免疫荧光检测 EIF3D 及其与 RUVBL1 的相互作用对细胞活力、集落形成、细胞凋亡和 DNA 损伤的影响,并通过小鼠异种移植实验检测对体内肿瘤发生的影响。通过概率单位回归分析确定 CRC 细胞对 5-Fu 的 IC50 值。通过 qRT-PCR 和/或 Western blot 分析 CRC 组织、细胞和/或异种移植肿瘤中 EIF3D、eIF4E、EIF3D 相关基因、γH2AX、Bcl-2、Bax 和 Cleaved Caspase-3/Caspase-3 的表达。
结果:EIF3D 和 RUVBL1 在 CRC 组织/细胞中高表达且呈正相关。在 CRC 细胞中,除了 eIF4E,5-Fu 处理均上调 EIF3D 和 RUVBL1 水平;此外,EIF3D 沉默而非 eIF4E 下调 RUVBL1 水平。同时,EIF3D 沉默降低了 5-Fu 的 IC50 值,并增强了 5-Fu 诱导的活力下降、集落形成抑制、凋亡促进、Bcl-2 下调以及 γH2AX、Bax 和 Cleaved Caspase-3/Caspase-3 的上调,但逆转了 5-Fu 触发的 RUVBL1 上调。RUVBL1 过表达抵消了 EIF3D 沉默诱导的 5-Fu 处理的 CRC 细胞活力下降和凋亡促进作用,以及 5-Fu 处理的小鼠的肿瘤发生抑制和凋亡促进作用。
结论:EIF3D 通过上调 RUVBL1 水平促进 CRC 对 5-Fu 的耐药性。
Oncotarget. 2017-1-31
Eur Rev Med Pharmacol Sci. 2020-2